The ability of tpCD4+ T cells to strongly activate cytotoxic CD8+ T cells with low PD-1 levels, together with their vigorous pro-inflammatory nature19, could bypass the immunosuppressive envinronment of solid tumours47,48, which might be exploited in vivo to activate naive CD8+ T cells against tumours. This evidence concerns the gene CD8A and neoplasm.